Personalized treatment of hepatitis B
Clinical and Molecular Hepatology
;
: 1-6, 2015.
Article
in English
| WPRIM
| ID: wpr-119043
ABSTRACT
There are seven approved drugs for treatment of hepatitis B. Professional guidelines provide a framework for managing patients but these guidelines should be interpreted in the context of the individual patient's clinical and social circumstances. Personalized management of hepatitis B can be applied based on prediction of the individual patient's risk of cirrhosis and hepatocellular carcinoma to guide the frequency and intensity of monitoring and urgency of treatment. It can also be applied to decisions regarding when to start treatment, which drug to use, and when to stop based on the individual patient's disease characteristics, preference, comorbidities and other mitigating circumstances.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Antiviral Agents
/
Hepatitis B virus
/
Risk Factors
/
Precision Medicine
/
Genotype
/
Hepatitis B
/
Liver Diseases
Type of study:
Etiology study
/
Practice guideline
/
Prognostic study
/
Risk factors
Limits:
Humans
Language:
English
Journal:
Clinical and Molecular Hepatology
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS